Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
4.390
-0.060 (-1.39%)
Feb 11, 2025, 2:05 PM EST - Market open
Company Description
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.
It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt.
The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Zhengye Biotechnology Holding Limited
Country | China |
Founded | 2004 |
IPO Date | Jan 7, 2025 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 286 |
CEO | Songlin Song |
Contact Details
Address: No.1 Lianmeng Road, Jilin Economic & Technical Development Zone Jilin, 132101 China | |
Phone | 86 432 6304 7008 |
Website | jlzybio.com |
Stock Details
Ticker Symbol | ZYBT |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | CNY |
IPO Price | $4.00 |
CIK Code | 0001975641 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Zhenfa Han | Director and Chairman of the Board |
Songlin Song | Chief Executive Officer |
Wenhua Sun | Director |
Ping Wang | Chief Financial Officer |
Zhongyao Liu | Vice General Manager |
Wei Lian | Vice General Manager |
Yawen Dong | Vice General Manager |
Yuyou He | Vice General Manager |
Wanlin Zhang | Vice General Manager |
Yuhong Cheng | Vice General Manager |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 14, 2025 | 6-K | Report of foreign issuer |
Jan 8, 2025 | 6-K | Report of foreign issuer |
Jan 7, 2025 | 424B4 | Prospectus |
Jan 6, 2025 | CERT | Certification by an exchange approving securities for listing |
Dec 20, 2024 | EFFECT | Notice of Effectiveness |
Dec 19, 2024 | 8-A12B | Registration of securities |
Dec 9, 2024 | POS AM | Post-Effective amendments for registration statement |
Nov 21, 2024 | FWP | Free Writing Prospectus |
Nov 15, 2024 | POS AM | Post-Effective amendments for registration statement |
Sep 30, 2024 | EFFECT | Notice of Effectiveness |